Protalex Inc.

PRTX on OTCQBToday's ChangeVolume52 Week Range (Low/Hi)Market Cap
1.10US 0.00/0.00%00.31 / 3.0031.64 M

Contact Information

Protalex Inc.

Headquarters:
131 Columbia Turnpike, Suite 1
Florham Park, New Jersey
USA, 07932
Tel: 215-862-9720
Email: Send a message
Website: Visit website
For more information...
Lead: Robert Thaemlitz

Protalex, Inc. is a clinical-stage biopharmaceutical company focused on the development of a class of drugs for treating autoimmune and inflammatory diseases including RA and Immune Thrombocytopenia (ITP). In the U.S., Protalex has open INDs for the treatment of RA and ITP and in Europe, an open IMPD for ITP. Please visit the Protalex website at www.protalex.com to learn more about Protalex and its lead drug candidate, PRTX-100.

Arnold P. Kling - President and Director

Kirk M. Warshaw - Chief Financial Officer, Secretary and Director

William E. Gannon, JR., M.D. - Chief Medical Officer

Arnold P. Kling - President and Director

Kirk M. Warshaw - Chief Financial Officer, Secretary and Director

Macro M. Elser - Director

 

Scientific Advisory Board

Benjamin Bowen, Ph.D - Chairman of Scientific Advisory Board

Michelle Catalina, Ph.D

James W. Dowe III - Vice Chairman of Scientific Advisory Board

Richard Francovitch, Ph.D

William E. Gannon, JR., M.D. - Chief Medical Officer

J. Bruce McClain, M.D.

Stock Information

Company Overview

Protalex, Inc. is a clinical-stage biopharmaceutical company focused on the development of a class of drugs for treating autoimmune and inflammatory diseases including RA and Immune Thrombocytopenia (ITP). In the U.S., Protalex has open INDs for the treatment of RA and ITP and in Europe, an open IMPD for ITP. Please visit the Protalex website at www.protalex.com to learn more about Protalex and its lead drug candidate, PRTX-100.

Management

Arnold P. Kling - President and Director

Kirk M. Warshaw - Chief Financial Officer, Secretary and Director

William E. Gannon, JR., M.D. - Chief Medical Officer

Board of Directors

Arnold P. Kling - President and Director

Kirk M. Warshaw - Chief Financial Officer, Secretary and Director

Macro M. Elser - Director

 

Scientific Advisory Board

Benjamin Bowen, Ph.D - Chairman of Scientific Advisory Board

Michelle Catalina, Ph.D

James W. Dowe III - Vice Chairman of Scientific Advisory Board

Richard Francovitch, Ph.D

William E. Gannon, JR., M.D. - Chief Medical Officer

J. Bruce McClain, M.D.

Contact Information

Headquarters:
131 Columbia Turnpike, Suite 1
Florham Park, New Jersey
07932, USA
Telephone: 215-862-9720
Email: Send a message
Website: Visit website